9th-Feb-2012 15:01Source: BSE

Biocon- Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

Biocon Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:

25th-Jan-2012 09:36Source: NSE

Biocon Limited

Biocon Limited has informed the Exchange regarding a press release dated January 24, 2012, titled "Biocon''s nine-month revenues driven by growth in Branded Formulations, Emerging Markets and Research...

25th-Jan-2012 08:03Source: BSE

Biocon- Announces Q3 Results, Limited Review report, Results Press Release & Fact Sheet for quarter ended on Dec 31, 2011

Biocon Ltd has announced the following results for the quarter ended December 31, 2011:

The Unaudited results for the Quarter ended December 31, 2011

The Company has posted a net profit ...

25th-Jan-2012 07:53Source: NSE

Biocon Limited

Biocon Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2011.

10th-Jan-2012 08:17Source: NSE

Biocon Limited

Biocon Limited has informed the Exchange regarding a press release dated January 09, 2012 titled "Biocon Announces Positive Efficacy Data with its Novel Monoclonal Antibody Itolizumab in a Pivotal Pso...

10th-Jan-2012 08:08Source: BSE

Biocon- Biocon Announces Positive Efficacy Data with its Novel Monoclonal Antibody Itolizumab in a Pivotal Psoriasis Study

Biocon Ltd has informed BSE regarding a Press Release dated January 09, 2012 titled "Biocon Announces Positive Efficacy Data with its Novel Monoclonal Antibody Itolizumab in a Pivotal Psoriasis Study"...

5th-Jan-2012 10:32Source: BSE

Biocon- Q3 results on Jan 24, 2012

Biocon Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 24, 2012, inter alia, to approve and take on record the unaudited financial results of the C...

21st-Dec-2011 13:36Source: NSE

Biocon Limited

Biocon Limited has informed the Exchange regarding a press release dated December 21, 2011, titled "Clinigene International Enters into Collaborative Clinical Research Services Agreement with Pacific ...

21st-Dec-2011 13:09Source: BSE

Biocon- Clinigene International Enters into Collaborative Clinical Research Services Agreement with Pacific Biomarkers

Biocon Ltd has informed BSE regarding a Press Release dated December 21, 2011 titled "Clinigene International Enters into Collaborative Clinical Research Services Agreement with Pacific Biomarkers"

20th-Oct-2011 11:23Source: NSE

Biocon Limited

Biocon Limited has informed the Exchange regarding a press release dated October 20, 2011, titled "Biocon launches INSUPen, a convenient and affordable reusable insulin delivery device".